Tagged: Food and Drug Administration (FDA)

In the Election Day scramble you might have missed that Pfizer got a new drug approved for rheumatoid arthritis.

Pfizer expects the twice-a-day pill called Xeljanz will be available in pharmacies later this month.

The drug won't come cheap. The wholesale price will run about $2,000 for a month's supply, the company says.

Two weeks after Matthew Spencer got a spinal injection for his chronic back pain, he felt "not quite right." Nothing too specific: worsening headache, nausea.

Then he saw a TV report on a recall of contaminated steroid medication used for back pain.

"I thought, well, I don't know if I had that medicine or not, but maybe I'd better go check it out," Spencer says.

The Food and Drug Administration has confirmed that it received five reports in the past past three years suggesting that people died after drinking caffeinated energy drinks.

But the agency also cautions that these reports do not add up to proof that the beverages actually caused those deaths. These reports — called adverse event reports — are considered unconfirmed allegations, and the FDA doesn't usually release them.